| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.738 | 12.425 | 42.356 | 41.208 | 17.633 | 10.452 | 11.214 | 7.282 | 2.102 | 0 |
| Total Income - EUR | 12.738 | 12.425 | 42.356 | 41.209 | 17.633 | 10.452 | 13.171 | 7.282 | 2.102 | 0 |
| Total Expenses - EUR | 6.600 | 7.863 | 12.835 | 15.531 | 7.097 | 4.584 | 5.084 | 5.531 | 4.951 | 5.146 |
| Gross Profit/Loss - EUR | 6.138 | 4.563 | 29.521 | 25.677 | 10.536 | 5.868 | 8.086 | 1.750 | -2.849 | -5.146 |
| Net Profit/Loss - EUR | 5.756 | 4.190 | 29.030 | 24.640 | 10.007 | 5.578 | 7.777 | 1.536 | -2.849 | -5.146 |
| Employees | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rosenheim Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 27.638 | 26.668 | 25.541 | 24.408 | 23.284 | 22.204 | 21.968 | 20.618 | 19.838 | 19.106 |
| Current Assets | 39.488 | 44.178 | 73.515 | 84.328 | 77.554 | 82.493 | 88.063 | 85.417 | 21.574 | 8.572 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 31.967 | 31.641 | 61.041 | 63.780 | 41.455 | 44.318 | 49.513 | 11.289 | 10.527 | 7.653 |
| Cash | 7.521 | 12.537 | 12.474 | 20.548 | 36.099 | 38.175 | 38.550 | 74.128 | 11.047 | 919 |
| Shareholders Funds | 66.825 | 70.334 | 98.173 | 92.514 | 100.730 | 104.399 | 109.860 | 35.436 | 32.479 | 27.151 |
| Social Capital | 2.589 | 2.563 | 2.520 | 2.473 | 2.426 | 2.380 | 2.327 | 2.334 | 2.327 | 2.314 |
| Debts | 301 | 512 | 882 | 16.222 | 108 | 298 | 171 | 70.598 | 8.933 | 527 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Rosenheim Med Srl